Below are the most recent publications written about "Fluoxetine" by people in Profiles.
-
Huang J, Liu X, Luo X, Tang C, Xu M, Wood L, Wang Y, Wang QM. Effects of Fluoxetine on Poststroke Dysphagia: A Clinical Retrospective Study. J Stroke Cerebrovasc Dis. 2018 Nov; 27(11):3320-3327.
-
Babb JA, Linnros SE, Commons KG. Evidence for intact 5-HT1A receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression. Neuropharmacology. 2018 10; 141:139-147.
-
Weaver SR, Fricke HP, Xie C, Lipinski RJ, Vezina CM, Charles JF, Hernandez LL. Peripartum Fluoxetine Reduces Maternal Trabecular Bone After Weaning and Elevates Mammary Gland Serotonin and PTHrP. Endocrinology. 2018 08 01; 159(8):2850-2862.
-
Barone I, Melani R, Mainardi M, Scabia G, Scali M, Dattilo A, Ceccarini G, Vitti P, Santini F, Maffei L, Pizzorusso T, Maffei M. Fluoxetine Modulates the Activity of Hypothalamic POMC Neurons via mTOR Signaling. Mol Neurobiol. 2018 Dec; 55(12):9267-9279.
-
Park S, Kim JM, Shin W, Han SW, Jeon M, Jang HJ, Jang IS, Kang J. BTNET : boosted tree based gene regulatory network inference algorithm using time-course measurement data. BMC Syst Biol. 2018 03 19; 12(Suppl 2):20.
-
Scabia G, Barone I, Mainardi M, Ceccarini G, Scali M, Buzzigoli E, Dattilo A, Vitti P, Gastaldelli A, Santini F, Pizzorusso T, Maffei L, Maffei M. The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF. Sci Rep. 2018 01 29; 8(1):1781.
-
Carson NJ, Progovac AM, Wang Y, Cook BL. A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills. Depress Anxiety. 2017 12; 34(12):1147-1156.
-
Fallon BA, Ahern DK, Pavlicova M, Slavov I, Skritskya N, Barsky AJ. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis. Am J Psychiatry. 2017 08 01; 174(8):756-764.
-
Benham RS, Hewage NB, Suckow RF, Engin E, Rudolph U. Prodepressant- and anxiogenic-like effects of serotonin-selective, but not noradrenaline-selective, antidepressant agents in mice lacking a2-containing GABAA receptors. Behav Brain Res. 2017 08 14; 332:172-179.
-
Ma M, Ren Q, Yang C, Zhang JC, Yao W, Dong C, Ohgi Y, Futamura T, Hashimoto K. Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling. Sci Rep. 2016 12 19; 6:39209.